New modulators in development by the CF-specific company could provide unique treatment options for the underlying cause of cystic fibrosis for many people with the disease
Site Search
Showing 1 - 3 of 3 results
Press Release
|
April 19, 2022
|
3 min read
Funding will support preclinical research and early-stage clinical trials
Press Release
|
Jan. 10, 2023
|
3 min read
Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to work alongside CF Foundation researchers at the Foundation’s therapeutics lab
Press Release
|
June 21, 2022
|
4 min read